These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12925455)

  • 41. Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.
    Dianati Maleki N; Van de Werf F; Goldstein P; Adgey JA; Lambert Y; Sulimov V; Rosell-Ortiz F; Gershlick AH; Zheng Y; Westerhout CM; Armstrong PW
    Heart; 2014 Oct; 100(19):1543-9. PubMed ID: 24916050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Routine early angioplasty after fibrinolysis for acute myocardial infarction.
    Cantor WJ; Fitchett D; Borgundvaag B; Ducas J; Heffernan M; Cohen EA; Morrison LJ; Langer A; Dzavik V; Mehta SR; Lazzam C; Schwartz B; Casanova A; Goodman SG;
    N Engl J Med; 2009 Jun; 360(26):2705-18. PubMed ID: 19553646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.
    Haverich A; Shernan SK; Levy JH; Chen JC; Carrier M; Taylor KM; Van de Werf F; Newman MF; Adams PX; Todaro TG; van der Laan M; Verrier ED
    Ann Thorac Surg; 2006 Aug; 82(2):486-92. PubMed ID: 16863750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
    Guptill JT; Mehta RH; Armstrong PW; Horton J; Laskowitz D; James S; Granger CB; Lopes RD
    Circ Cardiovasc Interv; 2013 Apr; 6(2):176-83. PubMed ID: 23549644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
    Fitch JC; Rollins S; Matis L; Alford B; Aranki S; Collard CD; Dewar M; Elefteriades J; Hines R; Kopf G; Kraker P; Li L; O'Hara R; Rinder C; Rinder H; Shaw R; Smith B; Stahl G; Shernan SK
    Circulation; 1999 Dec 21-28; 100(25):2499-506. PubMed ID: 10604887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pexelizumab Alexion.
    Whiss PA
    Curr Opin Investig Drugs; 2002 Jun; 3(6):870-7. PubMed ID: 12137406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort.
    Danchin N; Puymirat E; Steg PG; Goldstein P; Schiele F; Belle L; Cottin Y; Fajadet J; Khalife K; Coste P; Ferrières J; Simon T;
    Circulation; 2014 Apr; 129(16):1629-36. PubMed ID: 24657993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
    Zeymer U; Suryapranata H; Monassier JP; Opolski G; Davies J; Rasmanis G; Linssen G; Tebbe U; Schröder R; Tiemann R; Machnig T; Neuhaus KL;
    J Am Coll Cardiol; 2001 Nov; 38(6):1644-50. PubMed ID: 11704395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
    Toma M; Fu Y; Ezekowitz JA; McAlister FA; Westerhout CM; Granger CB; Armstrong PW
    Am Heart J; 2010 Oct; 160(4):671-7. PubMed ID: 20934561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Patel MR; Westerhout CM; Granger CB; Brener SJ; Fu Y; Siha H; Kim RJ; Armstrong PW
    Am Heart J; 2013 Feb; 165(2):226-33. PubMed ID: 23351826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.
    Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Gaudreault V; Proulx G; Barbeau G; Déry JP; Gleeton O; Manh-Nguyen C; Noël B; Roy L; Costerousse O; De Larochellière R;
    Am J Cardiol; 2010 Jun; 105(11):1520-7. PubMed ID: 20494655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
    Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
    Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study.
    Faxon DP; Gibbons RJ; Chronos NA; Gurbel PA; Sheehan F;
    J Am Coll Cardiol; 2002 Oct; 40(7):1199-204. PubMed ID: 12383565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.
    Wang TY; Chen AY; Alexander KP; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Am J Med; 2008 Sep; 121(9):805-10. PubMed ID: 18724971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
    Christenson RH; Vollmer RT; Ohman EM; Peck S; Thompson TD; Duh SH; Ellis SG; Newby LK; Topol EJ; Califf RM
    Am J Cardiol; 2000 Mar; 85(5):543-7. PubMed ID: 11078264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.